Twist Bioscience Stock Target Price and Analyst Consensus

TWST
 Stock
  

USD 53.91  0.94  1.77%   

The current analyst and expert consensus on Twist Bioscience is Hold, with 1 strong sell and 2 strong buy opinions. The current projected Twist Bioscience target price consensus is 136.67 with 3 analyst opinions. The most common way Twist Bioscience Corp analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Twist Bioscience executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Twist Bioscience. We encourage you to use your own analysis of Twist Bioscience Corp to validate this buy or sell advice. Twist Bioscience buy-or-sell recommendation module provides average expert sentiment on the projected Twist Bioscience Corp target price to derive its highest and lowest estimates based on projected price volatility of 55.075. Additionally, take a look at Macroaxis Advice on Twist Bioscience to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Twist Bioscience Direct Expenses is comparatively stable at the moment as compared to the past year. Twist Bioscience reported Direct Expenses of 72.56 Million in 2021. Revenues is likely to gain to about 128.5 M in 2022, whereas Net Income is likely to drop (188.7 M) in 2022.

Twist Bioscience Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Twist target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Twist target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions4
Lowered Outlook0
Raized Outlook0
Hold
Most Twist analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Twist stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Twist Bioscience Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Twist Bioscience Target Price Projection

Twist Bioscience's current and average target prices are 53.91 and 136.67, respectively. The current price of Twist Bioscience is the price at which Twist Bioscience Corp is currently trading. On the other hand, Twist Bioscience's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Twist Bioscience Market Quote on 15th of August 2022

Low Price51.09Odds
High Price53.97Odds

53.91

Target Price

Analyst Consensus On Twist Bioscience Target Price

Low Estimate100.0Odds
High Estimate200.0Odds
Number of Analysts3
Standard Deviation55.075

136.666

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Twist Bioscience Corp and the information provided on this page.

Twist Bioscience Analyst Ratings

Twist Bioscience's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Twist Bioscience stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Twist Bioscience's financials, market performance, and future outlook by experienced professionals. Twist Bioscience's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Twist Bioscience Target Price Projections

Twist Bioscience's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Twist Bioscience Corp and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Twist depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Twist Bioscience Corp including analysis of its current option contracts.
Twist Bioscience's latest option contracts expiring on 2022-08-19 are carrying combined implied volatility of 424.1 with a put-to-call open interest ratio of 0.72 over 28 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2022-08-19. The current put volume is at 42, with calls trading at the volume of 340. This yields a 0.12 put-to-call volume ratio. The Twist Bioscience option chain provides detailed quote and price information for the current Twist Bioscience Corp option contracts. It shows all of Twist Bioscience's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-08-19 Option Contracts

Twist Bioscience option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Twist Bioscience's lending market. For example, when Twist Bioscience's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Twist Bioscience, he or she must hedge the risk by shorting Twist Bioscience stock over its option's life.
The chart above shows Twist Bioscience's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Twist Bioscience's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Twist Bioscience's option, there is no secondary market available for investors to trade.

Twist Bioscience Maximum Pain Price across 2022-08-19 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Twist Bioscience close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Twist Bioscience's stock options are financial instruments that give investors the right to buy or sell shares of Twist Bioscience Corp common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Twist stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Twist Bioscience's stock price goes up or down, the stock options follow.
Additionally, take a look at Macroaxis Advice on Twist Bioscience to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Twist Bioscience Corp In The Money Call Balance

When Twist Bioscience's strike price is surpassing the current stock price, the option contract against Twist Bioscience Corp stock is said to be in the money. When it comes to buying Twist Bioscience's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Twist Bioscience Corp are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Twist Current Options Market Mood

Twist Bioscience's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Twist Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Twist Bioscience's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Twist Bioscience's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Twist Bioscience's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Twist Bioscience Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Twist Bioscience is a key component of Twist Bioscience valuation and have some predictive power on the future returns of a Twist Bioscience.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Twist Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Twist Bioscience in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
48.0653.9259.78
Details
Intrinsic
Valuation
LowReal ValueHigh
48.5273.0378.89
Details
Naive
Forecast
LowNext ValueHigh
52.8258.6964.55
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-4.92-4.79-4.57
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Twist Bioscience. Your research has to be compared to or analyzed against Twist Bioscience's peers to derive any actionable benefits. When done correctly, Twist Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Twist Bioscience Corp.

Additional Twist Bioscience Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Twist Bioscience is a key component of Twist Bioscience valuation and have some predictive power on the future returns of a Twist Bioscience.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Twist Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Twist Bioscience in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
48.0653.9259.78
Details
Intrinsic
Valuation
LowReal ValueHigh
48.5273.0378.89
Details
Naive
Forecast
LowNext ValueHigh
52.8258.6964.55
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-4.92-4.79-4.57
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Twist Bioscience. Your research has to be compared to or analyzed against Twist Bioscience's peers to derive any actionable benefits. When done correctly, Twist Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Twist Bioscience Corp.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum
Invested less than 1 share
Macroaxis Index
Invested over 40 shares
Baby Boomer Prospects
Invested less than 1 share
Additionally, take a look at Macroaxis Advice on Twist Bioscience to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Twist Bioscience Corp information on this page should be used as a complementary analysis to other Twist Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience Corp price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
The data published in Twist Bioscience's official financial statements usually reflect Twist Bioscience's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Twist Bioscience Corp. For example, before you start analyzing numbers published by Twist accountants, it's critical to develop an understanding of what Twist Bioscience's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Twist Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Twist Bioscience's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Twist Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Twist Bioscience Corp. Please utilize our Beneish M Score to check the likelihood of Twist Bioscience's management to manipulate its earnings.